EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetically Engineered IL12/CSF1R‐Macrophage Membrane‐Liposome Hybrid Nanovesicles for NIR‐II Fluorescence Imaging‐Guided and Membrane‐Targeted Mild Photothermal‐Immunotherapy of Glioblastoma

Pengfei Chen, Yue Liu, Haiyan Huang, Menglong Li, Hui Xie, Shubham Roy, Jingsi Gu, Jian Jin, Kai Deng, Lixin Du, Bing Guo iD

Advanced Science · 2025

DOI: 10.1002/advs.202500131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Pengfei Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traumatic Orthopedics, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China. Hauptthemen laut MEDLINE: Glioblastoma, Immunotherapy, Interleukin-12, Optical Imaging. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, China, Special Foundation for General Basic Research Program of Shenzhen, Guangdong Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is a big challenge for precision therapy of glioblastoma, mainly due to the existence of blood–brain barrier (BBB), tumor immunosuppressive microenvironment (TIM), and lack of efficient treatment paradigms. Herein, a theranostic nanoplatform for the second near‐infrared window (NIR‐II) fluorescence imaging‐guided membrane‐targeted mild photothermal‐immunotherapy of glioblastoma using genetically engineered CSF1R/IL12‐macrophage membrane (MM)‐liposome hybrid nanovesicles, is reported. By mimicking lipophilic membrane probe (Dil) with octadecyl chains, a NIR‐II emissive photothermal dye ( IRC18 ), which realizes labeling of nanovesicle lipid bilayers for biodistribution tracing, glioblastoma diagnosis, and molecular imaging of tumoral microenvironment, is synthesized. Importantly, MM and c‐RGD‐decorated liposome together offer BBB crossing, tumor targeting, and long‐term circulation; while, the genetically overexpressed CSF1R and IL12 on MM surface contribute to effective modulation of M2‐to‐M1 macrophage repolarization and local promotion of T cell cytotoxicity in glioblastoma microenvironment, respectively. Notably, through membrane fusion, IRC18 dyes translocate from nanovesicle lipid bilayers to glioblastoma membranes, which achieve membrane‐targeted mild photothermal therapy to ablate primary tumor and induce immunogenic cell death to promote antigen presentation. More importantly, the combined blockade of the CSF1‐CSF1R axis and IL‐12 enrichment not only reprograms the tumor microenvironment through macrophage M1 repolarization but also activates cytotoxic T cells, ultimately achieving complete glioblastoma eradication. This research provides an efficient theranostic paradigm for glioblastoma treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaImmunotherapyInterleukin-12Optical ImagingPhotothermal TherapyReceptors, Granulocyte-Macrophage Colony-Stimulating FactorBrain NeoplasmsAnimalsMiceLiposomesMacrophagesHumansTumor MicroenvironmentCell Line, TumorTheranostic NanomedicineGenetic Engineering

Stichwörter der Autor:innen

NIR‐II fluorescence imagingbiomimetic strategyglioblastomaimmunotherapyphotothermal therapy

Substanzen

LiposomesInterleukin-12Receptors, Granulocyte-Macrophage Colony-Stimulating Factor

Autor:innen und Institutionen

  • Department of Traumatic Orthopedics, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China.
  • School of Science, Shenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application, Harbin Institute of Technology, Shenzhen, 518055, China.
  • Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, Chengdu, 610041, China.
  • Education Center and Experiments and Innovations, Harbin Institute of Technology, Shenzhen, 518055, China.
  • Department of Medical Imaging, Shenzhen Longhua District Key Laboratory of Neuroimaging, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China.

ORCID-Profile: Bing Guo

Förderung

  • Ministry of Education, China
  • Special Foundation for General Basic Research Program of Shenzhen
  • Guangdong Basic and Applied Basic Research Foundation
  • National Natural Science Foundation of China
  • Shenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Chen, P., Liu, Y., Huang, H., Li, M., Xie, H., Roy, S., Gu, J., Jin, J., Deng, K., Du, L., & Guo, B. (2025). Genetically Engineered IL12/CSF1R‐Macrophage Membrane‐Liposome Hybrid Nanovesicles for NIR‐II Fluorescence Imaging‐Guided and Membrane‐Targeted Mild Photothermal‐Immunotherapy of Glioblastoma. Advanced Science. https://doi.org/10.1002/advs.202500131

Vancouver

Chen P, Liu Y, Huang H, Li M, Xie H, Roy S, et al. Genetically Engineered IL12/CSF1R‐Macrophage Membrane‐Liposome Hybrid Nanovesicles for NIR‐II Fluorescence Imaging‐Guided and Membrane‐Targeted Mild Photothermal‐Immunotherapy of Glioblastoma. Advanced Science. 2025. doi:10.1002/advs.202500131

BibTeX
@article{Chen2025,
  author = {Chen, Pengfei and Liu, Yue and Huang, Haiyan and Li, Menglong and Xie, Hui and Roy, Shubham and Gu, Jingsi and Jin, Jian and Deng, Kai and Du, Lixin and Guo, Bing},
  title = {Genetically Engineered IL12/CSF1R‐Macrophage Membrane‐Liposome Hybrid Nanovesicles for NIR‐II Fluorescence Imaging‐Guided and Membrane‐Targeted Mild Photothermal‐Immunotherapy of Glioblastoma},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202500131}
}
Kostenlos starten →